We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
WTW Stock Trading at a Discount to Industry at 13.47X: Time to Hold?
Read MoreHide Full Article
Key Takeaways
WTW's Q2 organic growth reached 7% in R&B, 4% in HWC and 6% in Insurance Consulting and Technology.
Propel AI targets $400 million in annualized savings by 2028, aiding WTW's goal of a 30% operating margin.
First-half free cash flow rose 66% to $360 million, while WTW plans $1 billion in share repurchases.
Willis Towers Watson Public Limited Company (WTW - Free Report) shares are trading at a discount compared with the Zacks Insurance – Brokerage industry. Its forward price-to-earnings multiple of 13.47X is lower than the industry average of 14.28X, the Finance sector’s 16.03X and the Zacks S&P 500 composite’s 19.81X.
The insurer has a market capitalization of $27.59 billion. The average volume of shares traded in the last three months was 0.5 million. The insurer’s earnings have a solid track record of beating estimates in each of the last four quarters, with an average of 3.88%.
Image Source: Zacks Investment Research
Shares of other insurers like Arthur J. Gallagher & Co. (AJG - Free Report) are trading at a multiple higher than the industry average, while Brown & Brown, Inc. (BRO - Free Report) and Aon plc. (AON - Free Report) are trading at a discount.
WTW Price Performance
Willis Towers Watson shares have lost 9.4% over the past year compared with the industry’s 19.1% decline.
Image Source: Zacks Investment Research
WTW’s Growth Projection Encourages
The Zacks Consensus Estimate for Willis Towers Watson's 2026 earnings per share indicates a year-over-year increase of 15.9%. The consensus estimate for 2026 revenues is $10.51 billion, implying an 8.2% year-over-year improvement.
The consensus estimate for 2027 earnings per share and revenues indicates an increase of 14.4% and 4.9%, respectively, from the corresponding 2026 estimates.
Expected long-term earnings growth is pegged at 17.5%, above the industry average of 14.3%.
Optimistic Analyst Sentiment on WTW
Two of the 11 analysts covering the stock have raised estimates for 2026 and 2027 over the past 60 days. Thus, the Zacks Consensus Estimate for 2026 and 2027 moved 0.1% and 0.4% north, respectively, in the last 60 days.
Image Source: Zacks Investment Research
WTW’s Favorable Return on Capital
Willis Towers Watson’s return on equity (ROE) of 22.2% for the trailing 12 months compared favorably with the industry’s 19.1%, reflecting the company’s efficiency in utilizing shareholders’ funds. This insurer targets mid-teens ROE over the long term.
Average Target Price for WTW Suggests Upside
Based on short-term price targets offered by 20 analysts, the Zacks average price target is $373.35 per share. The average suggests a potential 25.7% upside from the last closing price.
Factors Impacting WTW
Willis Towers Watson Public is positioned for sustainable growth, driven by its diversified business mix, strong Health consulting demand, specialized risk expertise and technology-led productivity gains. In the second quarter of 2026, Health, Wealth & Career (HWC) grew 4% organically, Risk & Broking (R&B) increased 7%, and Insurance Consulting and Technology advanced 6%, highlighting broad-based business momentum.
Health remains a key growth engine, delivering 8% organic growth in the quarter as rising healthcare costs and benefits complexity drove demand. Meanwhile, WTW’s specialization strategy supported 7% growth in CRB despite softer insurance pricing, demonstrating its ability to win business through expertise rather than market-rate increases alone. Acquisitions, including FlowStone Partners, Newfront and Cushon, further expand its wealth management, brokerage and retirement capabilities.
Profitability offers additional upside. Second-quarter operating margins expanded 100 basis points to 22.2% in R&B and 30 basis points to 24.1% in HWC. WTW’s Propel AI program targets approximately $400 million in annualized savings by 2028, with about $350 million expected to remain after reinvestment. Management is targeting an adjusted operating margin of approximately 30% in 2028.
Strong cash generation reinforces the investment case, with first-half 2026 free cash flow rising 66% year over year to $360 million. Planned technology investments and at least $1 billion in share repurchases reflect WTW’s focus on productivity and shareholder returns.
End Notes
Overall, WTW’s investment thesis rests on resilient organic growth, market-share gains and operating-margin expansion. A robust capital position over the years reflects its financial flexibility.
Key risks include softer insurance pricing, acquisition integration and execution of its AI-driven cost-saving initiatives.
Its solid growth projections as well as attractive valuations are other positives. Optimistic analyst sentiment and favorable ROE should continue to benefit Willis Towers over the long term. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image: Bigstock
WTW Stock Trading at a Discount to Industry at 13.47X: Time to Hold?
Key Takeaways
Willis Towers Watson Public Limited Company (WTW - Free Report) shares are trading at a discount compared with the Zacks Insurance – Brokerage industry. Its forward price-to-earnings multiple of 13.47X is lower than the industry average of 14.28X, the Finance sector’s 16.03X and the Zacks S&P 500 composite’s 19.81X.
The insurer has a market capitalization of $27.59 billion. The average volume of shares traded in the last three months was 0.5 million. The insurer’s earnings have a solid track record of beating estimates in each of the last four quarters, with an average of 3.88%.
Image Source: Zacks Investment Research
Shares of other insurers like Arthur J. Gallagher & Co. (AJG - Free Report) are trading at a multiple higher than the industry average, while Brown & Brown, Inc. (BRO - Free Report) and Aon plc. (AON - Free Report) are trading at a discount.
WTW Price Performance
Willis Towers Watson shares have lost 9.4% over the past year compared with the industry’s 19.1% decline.
Image Source: Zacks Investment Research
WTW’s Growth Projection Encourages
The Zacks Consensus Estimate for Willis Towers Watson's 2026 earnings per share indicates a year-over-year increase of 15.9%. The consensus estimate for 2026 revenues is $10.51 billion, implying an 8.2% year-over-year improvement.
The consensus estimate for 2027 earnings per share and revenues indicates an increase of 14.4% and 4.9%, respectively, from the corresponding 2026 estimates.
Expected long-term earnings growth is pegged at 17.5%, above the industry average of 14.3%.
Optimistic Analyst Sentiment on WTW
Two of the 11 analysts covering the stock have raised estimates for 2026 and 2027 over the past 60 days. Thus, the Zacks Consensus Estimate for 2026 and 2027 moved 0.1% and 0.4% north, respectively, in the last 60 days.
Image Source: Zacks Investment Research
WTW’s Favorable Return on Capital
Willis Towers Watson’s return on equity (ROE) of 22.2% for the trailing 12 months compared favorably with the industry’s 19.1%, reflecting the company’s efficiency in utilizing shareholders’ funds. This insurer targets mid-teens ROE over the long term.
Average Target Price for WTW Suggests Upside
Based on short-term price targets offered by 20 analysts, the Zacks average price target is $373.35 per share. The average suggests a potential 25.7% upside from the last closing price.
Factors Impacting WTW
Willis Towers Watson Public is positioned for sustainable growth, driven by its diversified business mix, strong Health consulting demand, specialized risk expertise and technology-led productivity gains. In the second quarter of 2026, Health, Wealth & Career (HWC) grew 4% organically, Risk & Broking (R&B) increased 7%, and Insurance Consulting and Technology advanced 6%, highlighting broad-based business momentum.
Health remains a key growth engine, delivering 8% organic growth in the quarter as rising healthcare costs and benefits complexity drove demand. Meanwhile, WTW’s specialization strategy supported 7% growth in CRB despite softer insurance pricing, demonstrating its ability to win business through expertise rather than market-rate increases alone. Acquisitions, including FlowStone Partners, Newfront and Cushon, further expand its wealth management, brokerage and retirement capabilities.
Profitability offers additional upside. Second-quarter operating margins expanded 100 basis points to 22.2% in R&B and 30 basis points to 24.1% in HWC. WTW’s Propel AI program targets approximately $400 million in annualized savings by 2028, with about $350 million expected to remain after reinvestment. Management is targeting an adjusted operating margin of approximately 30% in 2028.
Strong cash generation reinforces the investment case, with first-half 2026 free cash flow rising 66% year over year to $360 million. Planned technology investments and at least $1 billion in share repurchases reflect WTW’s focus on productivity and shareholder returns.
End Notes
Overall, WTW’s investment thesis rests on resilient organic growth, market-share gains and operating-margin expansion. A robust capital position over the years reflects its financial flexibility.
Key risks include softer insurance pricing, acquisition integration and execution of its AI-driven cost-saving initiatives.
Its solid growth projections as well as attractive valuations are other positives. Optimistic analyst sentiment and favorable ROE should continue to benefit Willis Towers over the long term. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.